John Finan, director with Baker Tilly joined the healthcare consulting team in 2017. He is a member of the life sciences advisory practice and leads Baker Tilly’s new pharmaceutical commercial excellence practice. The practice provides trusted advisory services for life science clients with growth optimization expectations through the design & deployment of a product’s development and launch.
- 18 years pharma industry experience serving commercial roles from sales representative, medical education, field sales management, product management to Vice President of sales and marketing
- Life Science Market Access Optimization team
- Provided clients with extensive experience and expertise designing pre-launch access and adaptability platforms
- Produced impactful and targeted commercial growth initiatives for both fast-tract launch and in-line market expansion
- Senior vice president, chief commercial officer, transition patient services
- Retail pharmacy and patient HUB support service
- Provided trade, distribution and pharmaceutical treatment transition from hospital to home services to the pharmaceutical industry
- Director, commercial operations practices, PwC
- Led commercial effectiveness advisory practice and function as lead advisory for strategic and tactical execution guidance
- Consulting experience
- Product development and launch strategy in retail
- Institutional and DoD/ VHA customer channels
- Design and construction of infrastructure and business policy for an in-house patient support HUB service for a global biopharma
- Design and construction of new business units with a focus on self-insured employers for a major pharma
- Commercial transformations for pharma, diagnostic and device clients
- Bio New Jersey Industry Group
- Bio Pennsylvania Industry Group
- AdvaMed – Medical Device Industry Trade Group
Location
Education
University of Hartford
Master of Business Administration
University of Rhode Island
Bachelor of Science in business administration
